Article

Endocrinology Month in Review: March 2022

Each month, our editorial staff compiles a month in review highlighting the most popular content from the past month. March's month in review features CGM news, calls for insulin co-pay caps, and info on the declining quality of US diets.

Editor's Note: Clicking in the center of the slide will redirect you to the affiliated article or video.

Related Videos
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Abdul Abdellatif, MD: Early Osteopenia Interventions Needed for Patients With Kidney Disease and Gout
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Related Content
Dhruv Kazi, MD | Credit: PCSK9 Forum
November 18th 2024

More than 50% of US Adults Considered Eligible for Semaglutide with Current Labeling

Patrick Campbell
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024
November 21st 2024

Diabetes Dialogue: News and Updates in Diabetes at AHA 2024

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
US FDA logo in black over a white background. | Credit: US Food and Drug Administration
November 2nd 2024

FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

Patrick Campbell
Diabetes Dialogue: Diabetes Tech Updates in October 2024
November 11th 2024

Diabetes Dialogue: Diabetes Tech Updates in October 2024

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Depagliflozin Lowers Risk of Decline in Late-Stage Kidney Disease
October 26th 2024

Dapagliflozin Lowers Risk of Decline in Late-Stage Kidney Disease

Victoria Johnson
Katherine R. Tuttle, MD, Clinical Professor of Medicine, University of Washington Medicine, and Executive Director for Research, Providence Health Care, and Regional Co-Principal Investigator, Institute of Translational Health Sciences, Providence Medical Research Center
October 26th 2024

Semaglutide Shows Benefit in CKD and Type 2 Diabetes Across Kidney Disease Severities

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.